A pilot study of brexpiprazole for bipolar depression

E. Sherwood Brown; Neusha Khaleghi; Erin Van Enkevort; Elena Ivleva; Alyson Nakamura; Traci Holmes; Brittany L. Mason; Chastity Escalante

doi:10.1016/j.jad.2019.02.056

journal article Apr 01, 2019

A pilot study of brexpiprazole for bipolar depression

E. Sherwood Brown Neusha Khaleghi Erin Van Enkevort Elena Ivleva Alyson Nakamura Traci Holmes Brittany L. Mason

Chastity Escalante

Journal of Affective Disorders Vol. 249 pp. 315-318 · Elsevier BV

View at Publisher Save 10.1016/j.jad.2019.02.056

Topics

No keywords indexed for this article. Browse by subject →

References

20

[1]

Barnes "A rating scale for drug-induced akathisia" Br. J. Psychiatry (1989) 10.1192/bjp.154.5.672

[2]

Correll "Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled trial" Am. J. Psychiatry (2015) 10.1176/appi.ajp.2015.14101275

[3]

Guy (1976)

[4]

Hobart "A randomized, placebo-controlled study of the efficacy and safety of fixed-dose brexpiprazole 2mg/d as adjunctive treatment of adults with major depressive disorder" J. Clin. Psychiatry (2018) 10.4088/jcp.17m12058

[5]

Hobart "Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study" Curr. Med. Res. Opin. (2018) 10.1080/03007995.2018.1430220

[6]

Kane "A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia" Schizophr. Res. (2015) 10.1016/j.schres.2015.01.038

[7]

Kessler "Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey" Arch. Gen. Psychiatry (1994) 10.1001/archpsyc.1994.03950010008002

[8]

Levine "SAFTEE: a technique for the systematic assessment of side effects in clinical trials" Psychopharmacol. Bull. (1986)

[9]

Maeda "Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator" J. Pharmacol. Exp. Ther. (2014) 10.1124/jpet.114.213793

[10]

Michalak "Development of the QoL.BD: a disorder-specific scale to assess quality of life in bipolar disorder" Bipolar Disord. (2010) 10.1111/j.1399-5618.2010.00865.x

[11]

Mohammed "Acute pharmacological treatment strategies for bipolar depression" Neuropsychiatry (Lond.) (2016)

[12]

A New Depression Scale Designed to be Sensitive to Change

Stuart A. Montgomery, Marie Åsberg

British Journal of Psychiatry 1979 10.1192/bjp.134.4.382

[13]

Posner "The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults" Am. J. Psychiatry (2011) 10.1176/appi.ajp.2011.10111704

[14]

Rush "The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms" Int. J. Methods Psychiatr. Res. (2000) 10.1002/mpr.79

[15]

Sachs "Effectiveness of adjunctive antidepressant treatment for bipolar depression" N. Engl. J. Med. (2007) 10.1056/nejmoa064135

[16]

Schmidt (1996)

[17]

Simpson "A rating scale for extrapyramidal side effects" Acta Psychiatr. Scand. Suppl. (1970) 10.1111/j.1600-0447.1970.tb02066.x

[18]

Spreen (1998)

[19]

Thase "Adjunctive brexpiprazole 1 and 3mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study" J. Clin. Psychiatry (2015) 10.4088/jcp.14m09689

[20]

A Rating Scale for Mania: Reliability, Validity and Sensitivity

R. C. Young, J. T. Biggs, V. E. Ziegler et al.

British Journal of Psychiatry 1978 10.1192/bjp.133.5.429

Metrics

29

Citations

20

References

Details

Published: Apr 01, 2019
Vol/Issue: 249
Pages: 315-318
License: View

Authors

E

E. Sherwood Brown

Department of Psychiatry The University of Texas Southwestern Medical Center Dallas Texas USA

Cite This Article

E. Sherwood Brown, Neusha Khaleghi, Erin Van Enkevort, et al. (2019). A pilot study of brexpiprazole for bipolar depression. Journal of Affective Disorders, 249, 315-318. https://doi.org/10.1016/j.jad.2019.02.056

A pilot study of brexpiprazole for bipolar depression

You May Also Like